Episode Details

The Health Marketing Daily — July 23, 2026 In this episode: • Novo Nordisk's oral semaglutide tablet is expected to launch in Germany in Q3 2026 — a commercial milestone that will sharply accelerate GLP-1 accessibility and reshape the weight management supplement market across Europe. • Spanish retail data shows health is now the primary driver of supermarket purchase decisions, with consumers actively scanning for functional ingredients — a direct brief for brands competing on health positioning at shelf. • An international investigation coordinated by Lighthouse Reports has revealed that Big Food companies have filed 239 legal cases globally to block health labelling, taxes, and new food regulations — a story with direct implications for how the regulatory environment for health claims and functional food marketing will evolve in Europe. • Refrigerated protein bar brand Perfect Snacks is doubling down on format innovation and ecommerce as mainstream momentum builds — a channel and product strategy story that has direct read-across for European sports nutrition and functional snack brands. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health